Anti-LPAR3 antibody (150-250 aa) (STJ11106157)

SKU:
STJ11106157

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:2000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: LPAR3
Gene ID: 23566
Uniprot ID: LPAR3_HUMAN
Immunogen Region: 150-250 aa
Specificity: A synthetic peptide corresponding to a sequence within amino acids 150-250 of human LPAR3 (NP_036284.1).
Immunogen Sequence: LLVWAIAIFMGAVPTLGWNC LCNISACSSLAPIYSRSYLV FWTVSNLMAFLIMVVVYLRI YVYVKRKTNVLSPHTSGSIS RRRTPMKLMKTVMTVLGAFV V
Tissue Specificity Most abundantly expressed in prostate, testes, pancreas, and heart, with moderate levels in lung and ovary. No detectable expression in brain, placenta, liver, skeletal muscle, kidney, spleen, thymus, small intestine, colon, or peripheral blood leukocytes.
Function Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. May play a role in the development of ovarian cancer. Seems to be coupled to the G(i)/G(o) and G(q) families of heteromeric G proteins.
Protein Name Lysophosphatidic Acid Receptor 3
Lpa Receptor 3
Lpa-3
Lysophosphatidic Acid Receptor Edg-7
Database Links Reactome: R-HSA-416476
Reactome: R-HSA-418594
Reactome: R-HSA-419408
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Lysophosphatidic Acid Receptor 3 antibody
Anti-Lpa Receptor 3 antibody
Anti-Lpa-3 antibody
Anti-Lysophosphatidic Acid Receptor Edg-7 antibody
Anti-LPAR3 antibody
Anti-EDG7 antibody
Anti-LPA3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance